Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
Ratios

Forte Biosciences (FBRX) Non Operating Income (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Non Operating Income for 5 consecutive years, with -$83000.0 as the latest value for Q4 2020.

  • Quarterly Non Operating Income changed N/A to -$83000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was -$205000.0 through Dec 2020, up 6.82% year-over-year, with the annual reading at -$396000.0 for FY2025, 108.42% down from the prior year.
  • Non Operating Income for Q4 2020 was -$83000.0 at Forte Biosciences, up from -$92000.0 in the prior quarter.
  • The five-year high for Non Operating Income was -$1000.0 in Q2 2019, with the low at -$762000.0 in Q2 2018.
  • Average Non Operating Income over 5 years is -$256055.6, with a median of -$214500.0 recorded in 2017.
  • The sharpest move saw Non Operating Income soared 99.87% in 2019, then crashed 1433.33% in 2020.
  • Over 5 years, Non Operating Income stood at -$456000.0 in 2016, then soared by 67.11% to -$150000.0 in 2017, then plummeted by 100.67% to -$301000.0 in 2018, then soared by 98.01% to -$6000.0 in 2019, then tumbled by 1283.33% to -$83000.0 in 2020.
  • According to Business Quant data, Non Operating Income over the past three periods came in at -$83000.0, -$92000.0, and -$7000.0 for Q4 2020, Q3 2020, and Q2 2020 respectively.